| Course | PAC 415 Healthcare Ethics |
|---|---|
| Module | Module 6 |
| Paper type | Harm reduction ethics paper |
| Length | About 1,011 words, 6 pages |
| Format | APA 7 student paper |
| School | Aspen University |
| Program | Psychology and Addiction Studies |
| Updated | September 2026 |
Free sample paper for PAC 415 Module 6
Keeping People Alive Long Enough to Recover: The Ethics of Harm Reduction
Student Name
Psychology and Addiction Studies Program, Aspen University
PAC 415: Healthcare Ethics
Instructor Name
Month Day, Year
Keeping People Alive Long Enough to Recover: The Ethics of Harm Reduction
The county served by Cedar Hollow Health recorded its highest number of overdose deaths last year. At a public meeting, the health department proposed three programs: wider distribution of naloxone, a syringe services program and, more controversially, a supervised consumption site. Some residents argued that these programs would save lives; others argued that they would condone and increase drug use. Clinic staff were asked for their views. This paper examines the ethics of harm reduction, weighs the objections, reviews the evidence for each program and considers where practical wisdom draws lines.
What Harm Reduction Means
Harm reduction is an approach that aims to reduce the health and social harms of substance use without requiring abstinence as a condition of help. It meets people where they are, treats them with dignity and recognizes that people who are alive and connected to services have more chances to recover. It includes practical measures such as naloxone, sterile syringes and testing for fentanyl, and it often serves as a bridge to treatment.
The Objections
Objections to harm reduction take several forms. Some argue that it sends the message that drug use is acceptable. Some fear that it increases use, crime or disorder in neighborhoods. Some believe that it prolongs addiction by making it safer, delaying the crisis that leads people to treatment. And some object on moral grounds to public resources supporting illegal activity. These objections deserve a serious hearing, and several are empirical claims that can be checked against evidence.
Naloxone Distribution
Overdose education and naloxone distribution trains people who use opioids and their families and friends to recognize an overdose and give naloxone. In Massachusetts, Walley et al. (2013) reported that the programs had trained 2,912 people as potential rescuers, who went on to report 327 overdose reversals, and that communities with any implementation had lower opioid overdose death rates than communities with none, with the largest reductions where enrollment was highest. The evidence is observational, but the intervention is simple and the benefit is a life.
Syringe Services
Syringe services programs provide sterile injection equipment to prevent infections such as HIV and hepatitis C, often with testing and referral. Pooling 12 studies in a meta-analysis, Aspinall et al. (2014) found that exposure to these programs was associated with reduced HIV transmission among people who inject drugs, with a stronger association in the six higher-quality studies, and concluded that they should be one component of a broader set of interventions.
Supervised Consumption
Supervised consumption sites let people use drugs they have obtained themselves under the observation of trained staff who can respond to overdoses. A systematic review of 75 articles by Potier et al. (2014) found that such services attracted the most marginalized people who inject drugs, promoted safer injection, improved access to primary care and reduced overdose frequency, and did not increase drug injecting, trafficking or crime in surrounding areas. Most studies came from Vancouver and Sydney, which limits how far the findings generalize, and legal questions about such sites remain unsettled in much of the United States.
Weighing the Programs
The table weighs each program against the principles.
| Program | Beneficence and nonmaleficence | Autonomy and justice | Main concern |
|---|---|---|---|
| Naloxone distribution | Prevents deaths; minimal risk | Serves anyone at risk | Few; largely resolved by evidence |
| Syringe services | Reduces HIV and hepatitis transmission | Reaches marginalized people | Community perception |
| Supervised consumption | Reduces overdose harm; links to care | Respects people not ready for treatment | Legal status; local acceptance; limited U.S. evidence |
Answering the Objections
The evidence addresses several objections directly. The review of supervised injection found no increase in drug use or crime, and syringe programs reduce disease without evidence of encouraging use. The argument that people must reach a crisis before recovering has a grim flaw: for many, the crisis is a fatal overdose. The moral objection deserves respect, but harm reduction does not require endorsing drug use, only caring for the people who use drugs. The principle of nonmaleficence argues against withholding measures that prevent death.
Where Practical Wisdom Draws Lines
Practical wisdom does not mean supporting every program everywhere. It means weighing evidence, local conditions and community concerns. For the county, naloxone distribution and syringe services have strong evidence and few drawbacks, and the clinic can support them fully. A supervised consumption site raises unresolved legal questions and would need careful community engagement, clear links to treatment and evaluation. The clinic can support exploring it while acknowledging those questions honestly.
The Counselor's Role
Counselors can practice harm reduction within their own work by providing naloxone and training to clients and families, discussing safer use with clients who are not ready to stop, avoiding judgment and keeping the door to treatment open. They can also speak at public meetings from their experience. Harm reduction and treatment are not opposites; many clients reach treatment through harm reduction services that kept them alive and treated them with respect.
Fentanyl Test Strips and Safer Supply Debates
Newer harm reduction measures raise their own questions. Fentanyl test strips let people check drugs for fentanyl before use, and many states changed their paraphernalia laws to allow them. Proposals to provide a safer supply of pharmaceutical opioids are far more contested, with debates about diversion and evidence that remain unsettled. Practical wisdom treats each measure on its own evidence rather than accepting or rejecting harm reduction as a single package.
Counselors who work in recovery-oriented programs sometimes worry that harm reduction conflicts with their mission. In practice the two share a commitment to the person's life and dignity, and clients often move between them over time.
Conclusion
Harm reduction rests on a simple ethical claim: people must be alive to recover, and they deserve care whether or not they are ready to stop using. Evidence supports naloxone distribution and syringe services strongly and supervised consumption substantially, while legal and community questions about the last remain. Weighing these programs with practical wisdom, honest about both evidence and concerns, lets a clinic support what saves lives while engaging its community respectfully.
References
Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., Palmateer, N., Doyle, J. S., Hellard, M. E., & Hutchinson, S. J. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. International Journal of Epidemiology, 43(1), 235-248. https://doi.org/10.1093/ije/dyt243
Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014). Supervised injection services: What has been demonstrated? A systematic literature review. Drug and Alcohol Dependence, 145, 48-68. https://doi.org/10.1016/j.drugalcdep.2014.10.012
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, Article f174. https://doi.org/10.1136/bmj.f174
PAC 415 Module 6 instructions, in plain terms
Aspen's PAC 415 examines ethical issues in health care from the perspective of addiction-related topics, and harm reduction is a debate this module often takes up. With the Module 6 text reserved for the course, this example analyzes harm reduction as a county would face it. Define harm reduction fairly and state its objections seriously. Treat empirical claims, such as whether a program increases drug use, as questions for evidence. Review the evidence for each measure separately rather than treating harm reduction as one thing. Weigh the programs against ethical principles. Take a position that reflects both evidence and remaining uncertainties. Describe what counselors can do in their own work and in public debate.
Inside the PAC 415 Module 6 example
The paper opens with the county's overdose deaths and three proposals. It defines harm reduction and sets out four objections. The evidence sections summarize a Massachusetts study in which 327 overdose reversals were reported and towns running the programs saw fewer opioid deaths, a meta-analysis of 12 studies linking syringe programs to reduced HIV transmission, and a review of 75 articles finding that supervised injection services reduced overdoses without increasing drug use or crime, mostly in Vancouver and Sydney. A four-column table weighs each program. Sections answer the objections, discuss fentanyl test strips and safer supply debates, draw lines with practical wisdom and describe the counselor's role.
Where the marks sit in the PAC 415 Module 6 rubric
Harm reduction papers are graded on fair presentation of the debate, accurate evidence, ethical analysis and a reasoned position. This example states objections respectfully and answers the empirical ones with evidence. Its three APA sources are Walley and colleagues' BMJ study of overdose education and naloxone distribution, Aspinall and colleagues' meta-analysis of needle and syringe programs and Potier and colleagues' systematic review of supervised injection services. Distinguishing the strength of support for each program, rather than taking a blanket position, shows the judgment a practical wisdom course rewards. Acknowledging the geographic limits of the supervised injection evidence and unsettled legal questions shows intellectual honesty. The paper also separates moral objections from factual ones, answering each on its own terms, which keeps the analysis fair to residents who oppose the programs.
Common PAC 415 Module 6 mistakes, and how to avoid them
Students often write harm reduction papers as advocacy pieces that ignore objections, or as opinion pieces without evidence. State the objections fairly and answer them with research where research exists. Treat each program separately, since the evidence differs. Note limits in the evidence, such as where studies were done. Distinguish moral objections, which deserve respectful engagement, from empirical claims, which can be tested. Include the counselor's practical role, such as providing naloxone. Avoid overstating findings from observational studies. If the meta-analysis statistics are confusing, a tutor can help you explain pooled effects and confidence intervals in plain words.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More PAC 415 and Psychology and Addiction Studies sample papers
- PAC 415 Module 1: Practical Wisdom in Ethics
- PAC 415 Module 2: Autonomy and Capacity
- PAC 415 Module 3: Beneficence and Client Goals
- PAC 415 Module 4: Justice and Access to Treatment
- PAC 415 Module 5: Confidentiality and Its Limits
- PAC 415 Module 7: A Complex Case, Several Principles
- PAC 415 Module 8: Reflection on Practical Wisdom
- PAC 310 Module 2: Ethical Decision-Making Model
- PAC 115 Module 2: Building and Decoding Terms
PAC 415 Module 6 questions, answered
What does PAC 415 Module 6 usually ask for?
Aspen's PAC 415 analyzes contemporary ethical issues from the perspective of addiction-related topics, and harm reduction and its ethical debates are a typical sixth-module topic. Follow your classroom prompt.
Does naloxone distribution reduce overdose deaths?
In Massachusetts, communities that implemented overdose education and naloxone distribution had lower opioid overdose death rates than communities that did not, with larger reductions where more people were trained.
Do supervised consumption sites increase drug use?
A systematic review of 75 articles found they reduced overdose frequency and improved access to care without increasing drug injecting, trafficking or crime nearby, though most studies came from Canada and Australia.
Where can I find a free PAC 415 Module 6 sample paper?
The whole paper is above, weighing naloxone distribution, syringe services and supervised consumption against the evidence and the principles in a four-column table.
Do syringe services programs reduce HIV?
A meta-analysis of 12 studies found exposure to these programs associated with reduced HIV transmission among people who inject drugs, especially in higher-quality studies.